Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. [electronic resource] by
- Buzdar, A U
- Hortobagyi, G N
- Frye, D
- Ho, D
- Booser, D J
- Valero, V
- Holmes, F A
- Birmingham, B K
- Bui, K
- Yeh, C
Producer: 19940131
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 12
Availability: No items available.
|
|
|
11.
|
|
|
|
12.
|
Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin. [electronic resource] by
- Dhingra, H M
- Valdivieso, M
- Booser, D J
- Umsawasdi, T
- Carr, D T
- Chiuten, D F
- Murphy, W K
- Issell, B F
- Spitzer, G
- Farha, P
Producer: 19840530
In:
Cancer treatment reports vol. 68
Availability: No items available.
|
|
|
13.
|
|
|
|
14.
|
Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer. [electronic resource] by
- Umsawasdi, T
- Valdivieso, M
- Booser, D J
- Barkley, H T
- Ewer, M
- MacKay, B
- Dhingra, H M
- Murphy, W K
- Spitzer, G
- Chiuten, D F
Producer: 19891130
In:
Cancer vol. 64
Availability: No items available.
|
|
|
15.
|
Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer. [electronic resource] by
- Umsawasdi, T
- Valdivieso, M
- Barkley, H T
- Booser, D J
- Chiuten, D F
- Murphy, W K
- Dhingra, H M
- Dixon, C L
- Farha, P
- Spitzer, G
Producer: 19850410
In:
International journal of radiation oncology, biology, physics vol. 11
Availability: No items available.
|
|
|
16.
|
Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. [electronic resource] by
- Umsawasdi, T
- Valdivieso, M
- Chen, T T
- Barkley, H T
- Booser, D J
- Chiuten, D F
- Dhingra, H M
- Murphy, W K
- Dixon, C L
- Farha, P
Producer: 19850104
In:
Journal of neuro-oncology vol. 2
Availability: No items available.
|
|
|
17.
|
The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer. [electronic resource] by
- Holmes, F A
- Valero, V
- Walters, R S
- Theriault, R L
- Booser, D J
- Fraschini, G
- Buzdar, A U
- Frye, D
- Gibbs, H R
- Hortobagyi, G N
Producer: 19940804
In:
Journal of the National Cancer Institute. Monographs no. 15
Availability: No items available.
|
|
|
18.
|
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. [electronic resource] by
- Holmes, F A
- Valero, V
- Walters, R S
- Theriault, R L
- Booser, D J
- Gibbs, H
- Fraschini, G
- Buzdar, A U
- Willey, J
- Frye, D
- Asmar, L
- Hortobagyi, G N
Producer: 19990811
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 10
Availability: No items available.
|
|
|
19.
|
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer. [electronic resource] by
- Holmes, F A
- Madden, T
- Newman, R A
- Valero, V
- Theriault, R L
- Fraschini, G
- Walters, R S
- Booser, D J
- Buzdar, A U
- Willey, J
- Hortobagyi, G N
Producer: 19961112
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14
Availability: No items available.
|
|
|
20.
|
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. [electronic resource] by
- Yang, C H
- Gonzalez-Angulo, A M
- Reuben, J M
- Booser, D J
- Pusztai, L
- Krishnamurthy, S
- Esseltine, D
- Stec, J
- Broglio, K R
- Islam, R
- Hortobagyi, G N
- Cristofanilli, M
Producer: 20061107
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|